Citations

Clear

4847 citation(s) found for "Tu, Eric".

A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS)
Bruno, Teresa L., Sanders, Jeremiah , Ning, Matthew S. , Ma, Jingfei , Klopp, Ann H. , Venkatesan, Aradhana M. , Martirosyan, Karen S. , Sanders, Jeremiah W , Ning, Matthew S , Ma, Jingfei , Klopp, Ann H , Martirosyan, Karen S , Venkatesan, Aradhana M , Wang, Li , Ding, Yao , Stafford, R. Jason , Lin, Eric, Bathala, Tharakeswara K , Wang, Jihong , Frank, Steven J.

Mayo Clinic

Cancers | May 20, 2024 | Volume: 16 | Issue: 10 | Pages: 1922

10.3390/cancers16101922 | PMID 38792000 Get It

Magnetic resonance imaging (MRI) can facilitate accurate organ delineation and optimal dose distributions in high-dose-rate (HDR) MRI-Assisted Radiosurgery (MARS). Its use for this purpose has been limited by the lack of positive-contrast MRI markers that can clearly delineate the lumen of the HDR applicator and precisely show the path of the HDR source on T1- and T2-weighted MRI sequences. We investigated a novel MRI positive-contrast HDR brachytherapy or interventional radiotherapy line marker, C4:S, consisting of C4 (visible on T1-weighted images) complexed with saline. Longitudinal relaxation time (T1) and transverse relaxation time (T2) for C4:S were measured on a 1.5 T MRI scanner. High-density polyethylene (HDPE) tubing filled with C4:S as an HDR brachytherapy line marker was tested for visibility on T1- and T2-weighted MRI sequences in a tissue-equivalent female ultrasound training pelvis phantom. Relaxivity measurements indicated that C4:S solution had good T1-weighted contrast (relative to oil [fat] signal intensity) and good T2-weighted contrast (relative to water signal intensity) at both room temperature (relaxivity ratio > 1; r2/r1 = 1.43) and body temperature (relaxivity ratio > 1; r2/r1 = 1.38). These measurements were verified by the positive visualization of the C4:S (C4/saline 50:50) HDPE tube HDR brachytherapy line marker on both T1- and T2-weighted MRI sequences. Orientation did not affect the relaxivity of the C4:S contrast solution. C4:S encapsulated in HDPE tubing can be visualized as a positive line marker on both T1- and T2-weighted MRI sequences. MRI-guided HDR planning may be possible with these novel line markers for HDR MARS for several types of cancer.
A Prospective, Multi-Center, Open-Label Assessment of Efficacy and Safety of the Quanta Dialysis System for Home Hemodialysis
Hussein, Wael F. , Atray, Naveen K., Bett, Doreen W., Chan, Christopher T. , Diamond, Matthew J., Green, Gopa B. , Karl, Bethany E., Kattah, Andrea G. , Seek, Melvin, Watnick, Suzanne , Weinhandl, Eric D. , Whitlock, Reid , Bismarck, Lisa, Gorbe, Kelley L., Komenda, Paul , Gupta, Nupur

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 34 | Issue: 11S | Pages: 177-177

10.1681/asn.20233411s1177a Get It

Performance of a Novel Race-Independent GFR Estimating Equation in Kidney Transplant Recipients Based on NMR-Measured Metabolites
Meeusen, Jeff W., Dasari, Surendra , Grassi, M , Stämmler, Frank , Schiffer, Eric, Meeusen, Jeffrey W. , Lieske, John C. , Grassi, Marcello

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 256-256

10.1681/asn.20223311s1256b Get It

Race Independent eGFR Equations in Assessing Renal Function in Patients With Liver Disease
Meeusen, Jeff W., Dasari, Surendra , Dubourg, Laurence , Stämmler, Frank , Schiffer, Eric, Meeusen, Jeffrey W. , Lieske, John C. , Lemoine, Sandrine

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 256-256

10.1681/asn.20223311s1256a Get It

Mutations to ALG5 Cause Autosomal Dominant Fibrocystic Kidney Disease
Lemoine, Hugo, Raud, Loann , Audrézet, Marie‐Pierre , Group, Genkyst Study, Olinger, Eric , Sayer, John A , Harris, Peter C. , Meur, Yannick Le , Gall, Émilie Cornec-Le , Group, Genkyst Study

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 32 | Issue: 10S | Pages: 402-402

10.1681/asn.20213210s1402b Get It

Transcriptomic Alterations of Angiogenesis Activity in Human Mesenchymal Stromal/Stem Cells in Diabetic Kidney Disease
Conley, Sabena M., Bian, Xiaohui , Zuckerman, Eric A. Zimmerman, Dehankar, Mrunal , Smith, Anastasia , Gowan, Cody, Snow, Zachary K. , Lerman, Lilach O. , Eirin, Alfonso , Zuckerman, Eric Zimmerman , Herrmann, Sandra M. , Jarmi, Tambi , Hickson, LaTonya J.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 32 | Issue: 10S | Pages: 241-241

10.1681/asn.20213210s1241a Get It

Dietary Intake and Risk of Incident and Recurrent Kidney Stones
Taylor, Eric N., Vaughan, Lisa E. , Mehta, Ramila A. , Chewcharat, Api , Thongprayoon, Charat , Enders, Felicity , Lieske, John C. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 175-175

10.1681/asn.20203110s1175a Get It

Flexible endoscopic intubation in emergency medicine: A mixed‐methods needs assessment
Sandefur, Benjamin J. , Brown, Calvin A. , Driver, Brian E. , Carlson, Jestin N. , Shappell, Eric F , Driver, Brian E , Campbell, Ronna L. , Mullan, Aidan F. , Park, Yoon Soo , Tekian, Ara

Mayo Clinic

AEM Education and Training | May 17, 2024 | Volume: 8 | Issue: 3 | Pages: No page available

10.1002/aet2.10992 | PMID 38765706 Get It

AbstractObjectivesThis needs assessment aimed to improve understanding of flexible endoscopic intubation training and practice in emergency medicine (EM), providing insights to educators and practice leaders seeking to improve education and practices.MethodsWe conducted a multicenter, mixed‐methods needs assessment of emergency physicians (EPs) incorporating focus groups and a survey. Focus groups comprised community EPs, academic EPs, and resident EPs. We analyzed focus group transcripts using grounded theory, qualitatively describing EM endoscopic intubation. The qualitative analysis shaped our survey instrument, which we deployed in cross‐sectional fashion. We report survey data with descriptive statistics.ResultsFocus groups with 13 EPs identified three themes: indications for use of endoscopic intubation, factors impacting a physician's decision to endoscopically intubate, and attaining and maintaining endoscopic intubation competency. Of 257 surveyed EPs (33% response rate), 79% had received endoscopic intubation training during residency, though 82% had performed this procedure 10 or fewer times in their career. Despite 97% acknowledging the necessity of competency, only 23% felt highly confident in their ability to perform endoscopic intubation. Participants (93%) reported scarce opportunities to perform the procedure and identified factors believed to facilitate competency acquisition and maintenance, including opportunities to perform endoscopic intubation in practice (98%), local champions (93%), and performing nasopharyngoscopy (87%).ConclusionsWhile most EPs acknowledged the importance of competency in endoscopic intubation, they reported scarce procedural opportunities and commonly expressed low confidence. Further research is needed on this topic, and we propose avenues to enhance education and practices related to endoscopic intubation. These include development of robust procedural curricula, support of local champions, and incorporating nasopharyngoscopy into EM practice.
Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial
Kawut, Steven M. , Feng, Rui , Ellenberg, Susan S. , Zamanian, Roham T. , Bull, Todd M., Chakinala, Murali M. , Mathai, Stephen C. , Hemnes, Anna R. , Lin, Grace , Andrew, Ruth , Stasinopoulos, Ioannis , Shou, Haochang , Song, Nianfu, Moutchia, Jude , Hemnes, Anna , Austin, Eric , Minhas, Jasleen , Ventetuolo, Corey E , Kawut, Steven M , Mathai, Stephen C , Doyle, Margaret F. , MacLean, Margaret R. , DeMichele, Angela , Minhas, Jasleen , Song, Nianfu, Ventetuolo, Corey E.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 15, 2024 | Volume: 210 | Issue: 9 | Pages: 1143-1151

10.1164/rccm.202402-0371oc | PMID 38747680 Get It

Abstract Rationale Inhibition of aromatase with anastrozole reduces pulmonary hypertension in experimental models. Objectives We aimed to determine whether anastrozole improved the 6-minute-walk distance (6MWD) at 6 months in pulmonary arterial hypertension (PAH). Methods We performed a randomized, double-blind, placebo-controlled phase II clinical trial of anastrozole in subjects with PAH at seven centers. Eighty-four postmenopausal women with PAH and men with PAH were randomized in a 1:1 ratio to receive anastrozole 1 mg or placebo by mouth daily, stratified by sex using permuted blocks of variable sizes. All subjects and study staff were masked. The primary outcome was the change from baseline in 6MWD at 6 months. By intention-to-treat analysis, we estimated the treatment effect of anastrozole using linear regression models adjusted for sex and baseline 6MWD. Assuming 10% loss to follow-up, we anticipated having 80% power to detect a difference in the change in 6MWD of 22 meters. Measurements and Main Results Forty-one subjects were randomized to placebo and 43 to anastrozole, and all received the allocated treatment. Three subjects in the placebo group and two in the anastrozole group discontinued the study drug. There was no significant difference in the change in 6MWD at 6 months (placebo-corrected treatment effect, −7.9 m; 95% confidence interval, −32.7 to 16.9; P = 0.53). There was no difference in adverse events between the groups. Conclusions Anastrozole did not show a significant effect on 6MWD compared with placebo in postmenopausal women with PAH and in men with PAH. Anastrozole was safe and did not have adverse effects. Clinical trial registered with www.clincialtrials.gov (NCT03229499).
Defining Benchmarks for Pelvic Exenteration Surgery
Brown, Kilian G. M. , Koh, Cherry , Sutton, Paul , Aguiar, Samuel , Bezerra, Tiago S. , Clouston, H.W., Desouza, Ashwin , Dozois, Eric J. , Ersryd, Amanda L., Frizelle, Frank , Funder, Jonas Amstrup , Garfinkle, Richard , Glyn, Tamara , Kanemitsu, Yukihide , Mens, David M , Palmer, Gabriella J., Pappou, Emmanouil P. , Quinn, Martha, Sahakitrungruang, Chucheep , Solbakken, Arne M. , Tiernan, Jim , Verhoef, Cornelis, Steffens, Daniel , Brown, Kilian G M , Solomon, Michael J. , García‐Aguilar, Julio , Heriot, Alexander G. , Kong, Chia Yew , Kristensen, Helle Ø , Malakorn, Songphol , Nilsson, Per Johan , Palmer, G. , Quyn, Aaron J. , Saklani, Avanish

Mayo Clinic

Annals of Surgery | May 15, 2024 | Volume: 282 | Issue: 6 | Pages: 1118-1126

10.1097/sla.0000000000006348 | PMID 38747145 Get It

Objective: To establish globally applicable benchmark outcomes for pelvic exenteration (PE) in patients with locally advanced primary rectal cancer (LARC) and locally recurrent rectal cancer (LRRC), using outcomes achieved at highly specialised centres. Background: PE is established as the standard of care for selected patients with LARC and LRRC. There are currently no available benchmarks against which surgical performance in PE can be compared for audit and quality improvement. Methods: This international multicentre retrospective cohort study included patients undergoing PE for LARC or LRRC at 16 highly experienced centres between 2018 and 2023. Ten outcome benchmarks were established in a lower-risk subgroup. Benchmarks were defined by the 75th percentile of the results achieved at the individual centres. Results: Seven hundred sixty-three patients underwent PE, of which 464 patients (61%) had LARCs and 299 (39%) had LRRCs. Five hundred forty-four patients (71%) who met predefined lower-risk criteria formed the benchmark cohort. For patients with LARC, the calculated benchmark threshold for major complication rate was ≤44%; Comprehensive Complication Index: ≤30.2; 30-day mortality rate: 0%; 90-day mortality rate: ≤4.3%; R0 resection rate: ≥79%. For patients with LRRC, the calculated benchmark threshold for major complication rate was ≤53%; Comprehensive Complication Index: ≤34.1; 30-day mortality rate: 0%; 90-day mortality rate: ≤6%; R0 resection rate: ≥77%. Conclusions: The reported benchmarks for PE in patients with LARC and LRRC represent the best available care for this patient group globally and can be used for rigorous assessment of surgical quality and to facilitate quality improvement initiatives at international exenteration centres.